CLASS II ONGOING Drug recall · Reported 30 Sep 2026 · FDA Enforcement Report

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye recalled

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare is recalling Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, distributed nationwide in the US. The recall was initiated on 15 Sep 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27; RL25H02, RL25H03, RL25H04, Exp. Date Aug-27; RL25K01, RL25K02, RL25K03, RL25K04, Exp. Date Sep-27; RL25M01, RL25M02, RL25M03, RL25M04, Exp. Date Oct-27; RL25N01, RL25N02, RL25N04, Exp. Date Nov-27.
Quantity recalled2,356,248 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0870-2026
FDA event ID
99909
Classification
Class II
Status
Ongoing
Recall initiated
15 Sep 2026
FDA classified
23 Sep 2026
Reported
30 Sep 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility
Drug class
Eye Drops

Timeline

15 Sep 2026Recall initiated by company
23 Sep 2026Classified by FDA+8 days
30 Sep 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15

Where it was distributed

Nationwide in the USA.

Nationwide

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility

Which lots are affected?

Lot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27; RL25H02, RL25H03, RL25H04, Exp. Date Aug-27; RL25K01, RL25K02, RL25K03, RL25K04, Exp. Date Sep-27; RL25M01, RL25M02, RL25M03, RL25M04, Exp. Date Oct-27; RL25N01, RL25N02, RL25N04, Exp. Date Nov-27.

Where was it sold?

Nationwide in the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 6 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 99909

This product is part of a recall event; the main page for the event is Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye recalled.

More recalls from Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare

All 4

Other Clear Eyes Redness Relief recalls

All 2